• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1078250-48
Device Problem Activation Failure (3270)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/07/2020
Event Type  malfunction  
Manufacturer Narrative
The device was received.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a de novo lesion located in the distal right coronary artery that was both moderately calcified and tortuous and 90% stenosed.A xience xpedition stent system was advanced to the target lesion, and during attempted deployment, the stent balloon completely failed to inflate even with 12 atmospheres of pressure.The stent delivery system was removed and the procedure was completed with another same size xience.There were no reported adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported activation failure including expansion failures/ failure to deploy was able to be confirmed as a longitudinal tear on the outer member was noted.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.As there was no damage noted to the device during the inspection prior to use and there was no report of a leak during preparation for use, the investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that inadvertent mishandling and/or interaction with the moderately calcified, tortuous and 90% stenosed anatomy/ or other devices resulted in the noted longitudinal tear on the outer member; thus resulting in the reported activation failure including expansion failures/ failure to deploy.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10505472
MDR Text Key206160735
Report Number2024168-2020-07482
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 10/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/08/2023
Device Catalogue Number1078250-48
Device Lot Number0022741
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/28/2020
Initial Date Manufacturer Received 08/17/2020
Initial Date FDA Received09/08/2020
Supplement Dates Manufacturer Received09/21/2020
Supplement Dates FDA Received10/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-